scispace - formally typeset
D

David Roder

Researcher at University of South Australia

Publications -  403
Citations -  9126

David Roder is an academic researcher from University of South Australia. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 42, co-authored 380 publications receiving 8081 citations. Previous affiliations of David Roder include Queen Elizabeth II Hospital & University of Michigan.

Papers
More filters
Journal ArticleDOI

The epidemiology of gastric cancer.

David Roder
- 01 Dec 2002 - 
TL;DR: It is estimated that the global burden of gastric cancer could be reduced by up to 50% by dietary changes that included an increased intake of fruit and vegetables.
Journal ArticleDOI

Factors Predictive of Corneal Graft Survival: Report from the Australian Corneal Graft Registry

TL;DR: Key predictors of graft failure were an indication for graft other than keratoconus or corneal dystrophy; a failed previous graft; aphakia; inflammation at the time of graft; presence of an anterior chamber or iris-clip intraocular lens; graft size outside the range of 7.0 to 7.9 mm diameter.
Journal ArticleDOI

Risk of cancer in patients with scleroderma: a population based cohort study

TL;DR: Evidence is provided that scleroderma is associated with cancer, and in particular, lung cancer, in South Australia and both diffuse and limited forms of sclerosis are associated with a similarly increased risk of cancer.
Journal ArticleDOI

Factors predictive of preferred place of death in the general population of South Australia

TL;DR: Multivariable analyses indicate that predictors of preferred home death include younger age, male, born in the UK/Ireland or Italy/Greece, better physical health, poorer mental health, and fewer concerns about dying at home.
Journal ArticleDOI

Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA.

TL;DR: Assessment of the association between survival of cervical cancer patients after diagnosis and the presence of human papillomavirus (HPV) RNA within the tumour was assessed retrospectively, suggesting that cervical carcinoma patients fall into two groups--a younger, HPV-RNA-positive group, with a better prognosis, and an older, HPV -RNA-negative group with poorer prognosis.